Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2012
05/03/2012US20120108609 Dihydrooxazol-2-amine derivatives
05/03/2012US20120108606 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same
05/03/2012US20120108605 O-glcnac transferase inhibitors and uses thereof
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108602 Carbamoyl Compounds as DGAT1 Inhibitors 190
05/03/2012US20120108599 Methods and compositions for the treatment of metabolic disorders
05/03/2012US20120108598 Sitagliptin synthesis
05/03/2012US20120108594 PROCESS FOR PREPARING SALTS OF 4-[[5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL]AMINO]-5-METHYL-N-PROPYLPYRROLO[2,1-f][1,2,4]TRIAZINE-6-CARBOXAMIDE AND NOVEL STABLE FORMS PRODUCED THEREIN
05/03/2012US20120108588 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives
05/03/2012US20120108587 Aza- and Diaza-Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
05/03/2012US20120108585 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators
05/03/2012US20120108583 Tricyclic Compounds As mPGES-1 Inhibitors
05/03/2012US20120108579 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
05/03/2012US20120108573 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/03/2012US20120108571 Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators
05/03/2012US20120108566 Nicotinamides as jak kinase modulators
05/03/2012US20120108554 PROCESS FOR PREPARING HIGH PURITY 1alpha-HYDROXY VITAMIN D2
05/03/2012US20120108550 Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments
05/03/2012US20120108548 Molecular tweezers for the treatment of amyloid-related diseases
05/03/2012US20120108508 Method for promoting secretion of glucagon-like peptide-1 by administering k-casein
05/03/2012US20120108507 Methods for In Vivo Cell Reprogramming
05/03/2012US20120108506 Agent For Suppressing Postprandial Elevation Of Blood Insulin Concentration
05/03/2012US20120108505 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
05/03/2012US20120108504 Leptin agonist and methods of use
05/03/2012US20120108503 Methods for treating type i diabetes with leptin and leptin agonists
05/03/2012US20120107928 Antibody Inhibitors of GDF-8 and Uses Thereof
05/03/2012US20120107432 Composition of extract of emblica officinalis and method of preparing the same
05/03/2012US20120107398 Pharmaceutical compositions
05/03/2012US20120107396 Compositions For The Treatment of Central Nervous System Disorders Including Depression Employing Novel Drug Combination Therapy To Reduce Suicidality In Patients
05/03/2012US20120107301 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
05/03/2012US20120107299 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
05/03/2012US20120107298 Use of LCAT for Treating Anemia and Red Blood Cell Dysfunction
05/03/2012US20120107296 Feed supplement
05/03/2012US20120107291 Bifidobacteria for treating diabetes and related conditions
05/03/2012US20120107287 Specialized medical nutrition for surgical and trauma patients containing probiotics
05/03/2012US20120107284 Stem cells for transplantation and methods for production thereof
05/03/2012US20120107281 Compositions and methods for modifying cell surface glycans
05/03/2012US20120107275 Fused heterocyclic derivatives and methods of use
05/03/2012DE102010043318A1 Calciumcarbonat enthaltende Zusammensetzung Calcium carbonate-containing composition
05/03/2012DE102008062136B4 Pharmazeutische Zusammensetzung auf Basis von Peptid aus Kamelmilch A pharmaceutical composition based on peptide from camel milk
05/03/2012CA2853974A1 Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives, substantially enantiomericallyp ure compositions and methods
05/03/2012CA2816321A1 Compositions and methods for inhibition of pcsk9 genes
05/03/2012CA2815419A1 Treating diabetes melitus using insulin injections administered with varying injection intervals
05/03/2012CA2815140A1 Glucose-dependent insulinotropic peptide analogs
05/03/2012CA2814846A1 Cyclic amine substituted oxazolidinone cetp inhibitor
05/03/2012CA2785887A1 Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis
05/02/2012EP2447265A1 Novel thiophene carboxamide derivative and medicinal use of same
05/02/2012EP2447254A1 Crystals
05/02/2012EP2446900A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446889A1 Difructose anhydride-containing composition for use in improving bowel movement
05/02/2012EP2445908A1 Disubstituted benzamide derivatives as glucokinase (gk) activators
05/02/2012EP2445901A1 New compounds, pharmaceutical composition and methods relating thereto
05/02/2012EP2445899A1 Novel fumarate salts of a histamine h3 receptor antagonist
05/02/2012EP2445507A1 Cross-linked polyallylamine tablet core
05/02/2012EP2445494A1 Treatment of insulin resistance and obesity by stimulating glp-1 release
05/02/2012EP2445360A1 Fish protein hydrolysate for the use thereof in inhibiting weight gain and/or weight loss
05/02/2012EP2445338A1 Synergistic combination to enhance blood glucose and insulin metabolism
05/02/2012EP1861403B1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
05/02/2012EP1730152B1 Tetrahydroquinoline derivatives and a process for preparing the same
05/02/2012EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both
05/02/2012EP1651616B1 Pyridazine derivatives and their use as therapeutic agents
05/02/2012EP1651605B1 Pyridyl derivatives and their use as therapeutic agents
05/02/2012EP1647546B1 Novel heteroaryl derivative
05/02/2012EP1634951B1 Novel protein
05/02/2012EP1627869B1 Vanilloid receptor modulators
05/02/2012EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
05/02/2012EP1517905B1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/02/2012EP1487431B1 Preventing and/or treating cardiovascular disease and/or associated heart failure
05/02/2012EP1389130B1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
05/02/2012EP1032403B1 Nutritional supplement for cerebral metabolic insufficiencies
05/02/2012CN1835759B Micronutrient supplement
05/02/2012CN102438991A Carbinol compound having heterocyclic linker
05/02/2012CN102438648A Tissue kallikrein for the treatment of pancreatic beta-cell dysfunction
05/02/2012CN102438642A Composition comprising green tea extract
05/02/2012CN102438624A Substituted fused pyrimidine compounds
05/02/2012CN102438623A Solid preparation containing npy y5 receptor antagonist
05/02/2012CN102438614A Pyrone analogs for therapeutic treatment
05/02/2012CN102433300A Method for constructing pancreatic stem cell line from human insulin and differentiating to insulin secretion cell
05/02/2012CN102432760A Quaternary amine konjac glucomannan adduct, its preparation method and application
05/02/2012CN102432675A Novel polypeptide compound
05/02/2012CN102432634A 2-amino-4-(2'-pyridine)-pyrimidine-2-peroxo vanadium ammonium salt complex, method for cultivating single crystal of 2-amino-4-(2'-pyridine)-pyrimidine-2-peroxo vanadium ammonium salt complex, and application of 2-amino-4-(2'-pyridine)-pyrimidine-2-peroxo vanadium ammonium salt complex
05/02/2012CN102432603A Preparation method and pharmacological effect of mangiferin hexa-butyl-esterified derivative
05/02/2012CN102432602A Mangiferin hepta-propyl-esterified derivative
05/02/2012CN102432601A Mangiferin penta-esterified derivative
05/02/2012CN102432599A Crystal form of oxalate of dipeptidyl peptidase inhibitor and preparation method and application thereof
05/02/2012CN102432598A Tricyclic compound, preparation method thereof and pharmaceutical application thereof
05/02/2012CN102430088A Formula and preparation process of multifunctional Chinese herbal medicine bag
05/02/2012CN102430076A Umbilici-applied weight-reducing powder
05/02/2012CN102430064A Composition for tonifying primordial qi and removing meridian obstruction and regulating blood and preparation method thereof
05/02/2012CN102430063A Process for extracting general flavone in reed leaves by supercritical CO2 method
05/02/2012CN102430062A Method for extracting free amino acid from reed rhizome
05/02/2012CN102430041A Method for extracting total saponins of cochinchinese asparagus root by using ultrasonic waves
05/02/2012CN102430040A Medicament for treating diabetes
05/02/2012CN102430039A Traditional Chinese medicinal composition for treating diabetes mellitus and preparation method thereof
05/02/2012CN102430029A Nano microcapsule for six ingredients with rehmannia and preparation process thereof
05/02/2012CN102430027A External hot-compress weight-reducing medicine for postpartum obesity
05/02/2012CN102430022A Weight-reducing health-care product and preparation method thereof
05/02/2012CN102430007A Weight-losing Chinese patent medicine capable of eliminating fat and treating fatty liver obesity
05/02/2012CN102430001A Compound rose-hip flavone preparation for preventing diabetes mellitus and preparation method thereof
05/02/2012CN102429977A Medicine for treating diabetes
1 ... 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 ... 1298